Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancerNamrata S. Patil, David S. Shames, Amelia Au‐Yeung et al.|Cancer Cell|2022Cited by 403
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockadeBarzin Y. Nabet, David S. Shames, Habib Hamidi et al.|Cancer Cell|2024Cited by 154
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cellsXiangnan Guan, Namrata S. Patil, Ruozhen Hu et al.|Nature|2024Cited by 121